Latest Tax Incentives News

Page 28 of 36
Critica Limited has declared a maiden Inferred Mineral Resource Estimate for its Jupiter Project, establishing it as Australia’s largest and highest-grade clay-hosted rare earth deposit. Early metallurgical testwork shows promising beneficiation results, positioning the company as a strategic player in the rare earths sector.
Maxwell Dee
Maxwell Dee
29 Apr 2025
Algorae Pharmaceuticals reports significant progress in its AI-driven drug discovery platform, unveiling 24 novel oncology targets and appointing a seasoned Chief Commercial Officer to bolster market readiness.
Ada Torres
Ada Torres
29 Apr 2025
Nyrada Inc. posted a significant $2.46 million loss for H1 FY25, driven by increased R&D spend, while advancing its lead drug NYR-BI03 into first-in-human trials following regulatory approval.
Ada Torres
Ada Torres
18 Feb 2025
Zelira Therapeutics has received a $1.15 million cash refund from the Australian Government’s R&D Tax Incentive Scheme, bolstering its working capital to advance clinical development and business operations.
Victor Sage
Victor Sage
18 Feb 2025
Ausmon Resources Limited has launched a Share Purchase Plan offering shareholders shares at an 8.6% discount, with potential tax credits for Australian investors. The move aims to strengthen the company’s balance sheet and fund exploration activities.
Maxwell Dee
Maxwell Dee
18 Feb 2025
SG Fleet Group reported robust first-half 2025 results, driven by strong delivery volumes and revenue growth across Australia, New Zealand, and the UK, despite ongoing pressures in the used vehicle market.
Victor Sage
Victor Sage
18 Feb 2025
SG Fleet Group reported a solid $41.1 million NPAT for the first half of 2025, driven by strong disposal volumes and fleet growth across Australia, New Zealand, and the UK. While profit dipped from last year, the company anticipates normalization in the second half.
Victor Sage
Victor Sage
18 Feb 2025
Neurizon Therapeutics reported a sharp rise in half-year losses to $7.28 million but marked significant progress with its lead drug NUZ-001 entering a major ALS clinical trial and securing critical regulatory designations.
Ada Torres
Ada Torres
17 Feb 2025
Chalice Mining has achieved a major metallurgical breakthrough at its Gonneville Project, enabling the production of saleable copper and nickel concentrates from low-grade ores without costly hydrometallurgical processing. This innovation promises to significantly reduce capital and operating costs while improving project margins.
Maxwell Dee
Maxwell Dee
17 Feb 2025
Carly Holdings Limited has agreed to merge its car subscription operations with Carbar Holdings in a $3.8 million deal, aiming to create a larger, more competitive player in Australia’s growing car subscription sector.
Victor Sage
Victor Sage
14 Feb 2025
Cycliq Group Limited reported an 18% revenue increase to $2.9 million for the half-year ending December 2024, driven by higher transaction values and a revamped marketing strategy, despite a modest net loss of $211,214.
Sophie Babbage
Sophie Babbage
12 Feb 2025
Echo IQ has secured a $1.26 million refund under the Australian Government's R&D Tax Incentive, reinforcing its commitment to AI-driven solutions for structural heart disease detection.
Victor Sage
Victor Sage
12 Feb 2025